196 related articles for article (PubMed ID: 22739561)
61. [QTU pattern in a patient with the Anderson-Tawil syndrome].
Ciurzyński M; Bienias P; Kostera-Pruszczyk A; Pruszczyk P
Kardiol Pol; 2010 Mar; 68(3):339-41; discussion 342. PubMed ID: 20411461
[TBL] [Abstract][Full Text] [Related]
62. Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries?
Wheeler M; Grigg L; Zentner D
Congenit Heart Dis; 2014; 9(4):326-32. PubMed ID: 24151816
[TBL] [Abstract][Full Text] [Related]
63. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
64. Ventricular tachycardia and ventricular fibrillation.
Srivathsan K; Ng DW; Mookadam F
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
[TBL] [Abstract][Full Text] [Related]
65. Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis.
Bernardo P; Conforti ML; Bellando-Randone S; Pieragnoli P; Blagojevic J; Kaloudi O; Guiducci S; Porta F; Padeletti L; Gensini GF; Matucci-Cerinic M
J Rheumatol; 2011 Aug; 38(8):1617-21. PubMed ID: 21632680
[TBL] [Abstract][Full Text] [Related]
66. [Utilization of implantable ventricular defibrillators (with an analysis of the value of antiarrhythmics in the treatment of potentially fatal ventricular arrhythmias].
Waleffe A
Rev Med Liege; 2000 Apr; 55(4):307-14. PubMed ID: 10909319
[TBL] [Abstract][Full Text] [Related]
67. Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan.
Horigome H; Nagashima M; Sumitomo N; Yoshinaga M; Ushinohama H; Iwamoto M; Shiono J; Ichihashi K; Hasegawa S; Yoshikawa T; Matsunaga T; Goto H; Waki K; Arima M; Takasugi H; Tanaka Y; Tauchi N; Ikoma M; Inamura N; Takahashi H; Shimizu W; Horie M
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):10-7. PubMed ID: 19996378
[TBL] [Abstract][Full Text] [Related]
68. Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome.
Moreno-Manuel AI; Gutiérrez LK; Vera-Pedrosa ML; Cruz FM; Bermúdez-Jiménez FJ; Martínez-Carrascoso I; Sánchez-Pérez P; Macías Á; Jalife J
Cardiovasc Res; 2023 May; 119(4):919-932. PubMed ID: 35892314
[TBL] [Abstract][Full Text] [Related]
69. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
70. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
71. Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome.
Ballester LY; Benson DW; Wong B; Law IH; Mathews KD; Vanoye CG; George AL
Hum Mutat; 2006 Apr; 27(4):388. PubMed ID: 16541386
[TBL] [Abstract][Full Text] [Related]
72. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
[TBL] [Abstract][Full Text] [Related]
73. Andersen-Tawil syndrome. A diagnostic challenge.
Reyes Villatoro MA; Márquez MF; Gómez-Flores J; Nava S; Colín L; Iturralde P
Int J Cardiol; 2016 Feb; 205():163-164. PubMed ID: 26736094
[No Abstract] [Full Text] [Related]
74. Catheter ablation of frequent monomorphic ventricular arrhythmias in Andersen-Tawil syndrome: case report and focused literature review.
Keegan R; Onetto L; Gregorietti F; Urruti R; Di Biase L
J Interv Card Electrophysiol; 2023 Apr; 66(3):729-736. PubMed ID: 34665385
[TBL] [Abstract][Full Text] [Related]
75. [Cardiac arrhythmias during pregnancy--what to do?].
Trappe HJ
Herz; 2003 May; 28(3):216-26. PubMed ID: 12756479
[TBL] [Abstract][Full Text] [Related]
76. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
[TBL] [Abstract][Full Text] [Related]
77. Phenotype variability in patients carrying KCNJ2 mutations.
Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
[TBL] [Abstract][Full Text] [Related]
78. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
[TBL] [Abstract][Full Text] [Related]
79. A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome.
Chan HF; Chen ML; Su JJ; Ko LC; Lin CH; Wu RM
J Hum Genet; 2010 Mar; 55(3):186-8. PubMed ID: 20111058
[TBL] [Abstract][Full Text] [Related]
80. Atrial pacing for the management of ventricular arrhythmias in Andersen-Tawil syndrome.
Fadahunsi O; Shaikh B; Rettew A; Bennett K; Scollan D
HeartRhythm Case Rep; 2015 Sep; 1(5):352-355. PubMed ID: 28491582
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
